Skip to main content
SpringerLink
Log in

Procalcitonin in patients with acute coronary syndromes and cardiogenic shock submitted to percutaneous coronary intervention

  • IM - Original
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

Abstract

Procalcitonin (PCT) is known to be a biological diagnostic marker for severe sepsis, or septic shock in critically ill patients. There are still contrasting data about a role of procalcitonin in patients with acute myocardial infarction or cardiogenic shock, and in those with acute coronary syndromes, that is, non-ST-elevation myocardial infarction or unstable angina. We evaluated plasma levels of procalcitonin and C-reactive protein (CRP) in 52 patients admitted to our intensive cardiac care unit (ICCU): 14 patients with cardiogenic shock (CS) following ST-elevation myocardial infarction (STEMI), 15 patients with uncomplicated ST-elevation myocardial infarction (STEMI), and 24 with non-ST-elevation myocardial infarction or unstable angina (NSTEMI/UA). In all patients, infective processes were excluded. Procalcitonin values were significantly higher in CS patients with respect to the other two subgroups (P < 0.001, P < 0.001) while CRP levels were higher than NSTEMI/UA patients (P < 0.001) but not with respect to STEMI patients (P = 0.063). No correlations were found in cardiogenic shock patients between CRP and PCT values (R = 0.02; P = 0.762, ns). Procalcitonin levels measured on ICCU admission are significantly higher in patients with cardiogenic shock following the acute myocardial infarction, and they are not correlated with those of CRP. The degree of myocardial ischemia (clinically indicated by the whole spectrum of ACS, from unstable angina to cardiogenic shock ST-elevation following myocardial infarction) and the related inflammatory-induced response are better reflected by CRP (which was positive in most acute cardiac care patients of all our subgroups), than by PCT which seems more reflective of a higher degree of inflammatory activation, being positive only in all CS patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Conlon JM, Grimelius L, Thim L (1988) Structural characterization of a high-molecular-mass form of calcitonin [procalcitonin-(60–116)-peptide] and its corresponding N-terminal flanking peptide [procalcitonin-(1–57)-peptide] in a human medullary thyroid carcinoma. Biochem J. 256:245–250

    PubMed  CAS  Google Scholar 

  2. Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY (2006) Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 34:1996–2003

    Article  PubMed  CAS  Google Scholar 

  3. Geppert A, Steiner A, Delle-Karth G, Heinz G, Huber K (2003) Usefulness of procalcitonin for diagnosing complicating sepsis in patients with cardiogenic shock. Intensive Care Med 29:1384–1389

    Article  PubMed  Google Scholar 

  4. Kafkas N, Venetsanou K, Patsilinakos S, Voudris V, Antonatos D, Kelesidis K, Baltopoulos G, Maniatis P, Cokkinos DV (2008) Procalcitonin in acute myocardial infarction. Acute Card Care 10:30–36

    Article  PubMed  Google Scholar 

  5. Remskar M, Horvat M, Hojker S, Noc M (2002) Procalcitonin in patients with acute myocardial infarction. Wien Klin Wochenschr 114:205–210

    PubMed  CAS  Google Scholar 

  6. Buratti T, Ricevuti G, Pechlaner C, Joannidis M, Wiedermann FJ, Gritti D, Herold M, Wiedermann CJ (2001) Plasma levels of procalcitonin and interleukin-6 in IMA. Inflammation 25:97–100

    Article  PubMed  CAS  Google Scholar 

  7. Califf RM, Bengtson JR (1994) Cardiogenic shock. N Engl J Med 330:1724–1730

    Article  PubMed  CAS  Google Scholar 

  8. Holmes DR Jr (2003) Cardiogenic shock: a lethal complication of acute myocardial infarction. Rev Cardiovasc Med 4:131–135 Review

    PubMed  Google Scholar 

  9. Hochman JS (2003) Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation 107:2998–3002

    Article  PubMed  Google Scholar 

  10. Webb JG, Lowe AM, Sanborn TA et al (2003) Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial: SHOCK Investigators. J Am Coll Cardiol 42:1380–1386

    Article  PubMed  Google Scholar 

  11. Valente S, Lazzeri C, Vecchio S, Giglioli C, Margheri M, Bernardo P, Comeglio M, Chiocchini S, Gensini GF (2007) Predictors of in-hospital mortality after percutaneous coronary intervention for cardiogenic shock. Int J Cardiol 114:176–182

    Article  PubMed  Google Scholar 

  12. Valente S, Lazzeri C, Chiostri M, Sori A, Giglioli C, Salvadori C, Gensini GF (2008) Time of onset and outcome of cardiogenic shock in acute coronary syndromes. J Cardiovasc Med (Hagerstown) 9:1235–1240

    Google Scholar 

  13. Thygesen K, Alpert JS, White HD (2007) Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Universal Definition of Myocardial Infarction. J Am Coll Cardiol 50:2173–2195

    Article  PubMed  Google Scholar 

  14. ACC/AHA (2007) Guidelines for the management of patients with unstable angina/non–ST-elevation myocardial infarction. J Am Coll Cardiol 50:e1–e157

    Google Scholar 

  15. Whicher J, Bienvenu J, Monneret G (2001) Procalcitonin as an acute phase marker. Ann Clin Biochem 38:483–493

    Article  PubMed  CAS  Google Scholar 

  16. Nijsten MW, Olinga P, The TH et al (2000) Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med 28:458–461

    Article  PubMed  CAS  Google Scholar 

  17. Oberhoffer M, Stonans I, Russwurm S et al (1999) Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro. J Lab Clin Med 134:49–55

    Article  PubMed  CAS  Google Scholar 

  18. Sentürk T, Cordan J, Baran I, Ozdemir B, Güllülü S, Aydinlar A, Göral G (2007) Procalcitonin in patients with acute coronary syndrome: correlation with high-sensitive C-reactive protein, prognosis and severity of coronary artery disease. Acta Cardiol 62:135–141

    Article  PubMed  Google Scholar 

  19. Brunkhorst FM, Clark AL, Forycki ZF, Anker SD (1999) Pyrexia, procalcitonin, immune activation and survival in cardiogenic shock: the potential importance of bacterial translocation. Int J Cardiol 72:3–10

    Article  PubMed  CAS  Google Scholar 

  20. Aouifi A, Piriou V, Bastien O, Blanc P, Bouvier H, Evans R, Célard M, Vandenesch F, Rousson R, Lehot JJ (2000) Usefulness of procalcitonin for diagnosis of infection in cardiac surgical patients. Crit Care Med 28:3171–3176

    Article  PubMed  CAS  Google Scholar 

  21. de Werra I, Jaccard C, Corradin SB, Chioléro R, Yersin B, Gallati H, Assicot M, Bohuon C, Baumgartner JD, Glauser MP, Heumann D (1997) Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med 25:607–613

    Article  PubMed  Google Scholar 

Download references

Conflict of interest statement

The authors declare that they have no conflict of interest related to the publication of this manuscript.

Author information

Authors and Affiliations

  1. Intensive Cardiac Care Unit, Azienda Ospedaliero-Universitaria Careggi, Viale Morgagni 85, 50184, Florence, Italy

    Claudio Picariello, Chiara Lazzeri, Marco Chiostri, Gianfranco Gensini & Serafina Valente

Authors
  1. Claudio Picariello
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chiara Lazzeri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marco Chiostri
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gianfranco Gensini
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Serafina Valente
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Serafina Valente.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Picariello, C., Lazzeri, C., Chiostri, M. et al. Procalcitonin in patients with acute coronary syndromes and cardiogenic shock submitted to percutaneous coronary intervention. Intern Emerg Med 4, 403–408 (2009). https://doi.org/10.1007/s11739-009-0277-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-009-0277-9

Keywords

Search

Navigation